Redox Regulation of Programmed Cell Death in Lymphocytes
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Free Radical Research
- Vol. 22 (5), 389-397
- https://doi.org/10.3109/10715769509147548
Abstract
A redox imbalance caused by an over-production of prooxidants or a decrease in antioxidants seems to play a role in the programmed cell death that occurs in various developmental programs. Such a physiological function for oxidative stress is particularly applicable to the immune system, wherein individual lymphocytes undergo continuous scrutiny to determine if they should be preserved or programmed to die. Following activation, lymphocytes produced increased levels of reactive oxygen species (ROS) which may serve as intracellular signaling molecules. The ultimate outcome of this increased ROS formation, i.e., lymphocyte proliferation versus programmed cell death, may be dictated by macrophage-derived costimulatory molecules that bolster or diminish lymphocyte antioxidant defenses. HIV-1-infected individuals display multiple symptoms of redox imbalance consistent with their being in oxidative stress, and lymphocytes from such individuals are more prone to undergo apoptosis in vitro. It is suggested that oxidative stress is a physiological mediator of programmed cell death in lymphoid cells, and that HIV disease represents an extreme case of what can happen when regulatory safeguards are compromised.Keywords
This publication has 71 references indexed in Scilit:
- Oxidative stress as a mediator of apoptosisImmunology Today, 1994
- Programmed cell death, apoptosis and killer genesImmunology Today, 1993
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Activation-induced cell death (apoptosis) of mature peripheral T lymphocytesImmunology Today, 1993
- N‐Acetylcysteine inhibits apoptosis and decreases viral particles in HIV‐chronically infected U937 cellsFEBS Letters, 1993
- The role of reactive oxygen species, antioxidants and phytopharmaceuticals in human immunodeficiency virus activityMedical Hypotheses, 1993
- Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulationImmunology Today, 1992
- Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-(α is mediated by lipoxygenase metabolites of arachidonic acidBiochemical and Biophysical Research Communications, 1992
- Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytesInternational Journal of Immunopharmacology, 1991
- Quantitative aspects of the feeder cell phenomenon: Mechanistic implicationsBiochemical and Biophysical Research Communications, 1988